GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
As of 04:38PM GMT. Market open.
| Previous close | 1,636.60 |
| Open | 1,627.20 |
| Bid | 1,598.40 x 0 |
| Ask | 1,658.00 x 0 |
| Day's range | 1,620.80 - 1,653.80 |
| 52-week range | 1,190.80 - 1,737.00 |
| Volume | |
| Avg. volume | 9,379,232 |
| Market cap | 82.884B |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 19.31 |
| EPS (TTM) | 85.30 |
| Earnings date | 09 Feb 2022 |
| Forward dividend & yield | 0.80 (5.04%) |
| Ex-dividend date | 18 Nov 2021 |
| 1y target est | 1,651.80 |
- The Telegraph
Unilever slashes 1,500 management jobs in wake of failed Glaxo bid
Unilever plans to cut 1,500 management jobs as part of a major overhaul following its failed £50bn bid for GlaxoSmithKline's healthcare division.
- Reuters
Unilever's soap opera: M&A, job cuts and grumpy investors
Here are key developments around Unilever in the past two months. Unilever agreed to sell its global tea business to CVC Capital Partners for 4.5 billion euros ($5.1 billion), concluding a process of reviewing and spinning off the division that took more than two years. Unilever confirmed it had approached GlaxoSmithKline about buying its consumer goods business following media reports.
- Yahoo Finance UK
Unilever to cut 1,500 jobs worldwide in company shake-up
Unilever will reduce staff numbers in more than 100 countries in a bid to shore up its finances and take on a more competitive operating model.
© 2022 Yahoo. All rights reserved.
